Assignee
NEURACLE SCIENCE CO LTD
KR·22 granted patents·17 pending applications·117 citations·filing 2013–2025
Top patents by PatentIndex Score
39 records- 0196US11739141B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2020·Granted Aug 29, 2023·7 cites·16 claims
- 0295US11618783B2Anti-FAM19A5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2018·Granted Apr 4, 2023·9 cites·19 claims
- 0394US11746149B2Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucomaNEURACLE SCIENCE CO LTD·Filed 2018·Granted Sep 5, 2023·10 cites·20 claims
- 0494US11560425B2Use of anti-FAM19A5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2018·Granted Jan 24, 2023·12 cites·20 claims
- 0594US11332521B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 17, 2022·12 cites·20 claims
- 0694US11155613B2Use of anti-FAM19A5 antibodies for treating fibrosisNEURACLE SCIENCE CO LTD·Filed 2018·Granted Oct 26, 2021·15 cites·20 claims
- 0794US10640557B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 5, 2020·11 cites·18 claims
- 0893US9579398B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2013·Granted Feb 28, 2017·22 cites·24 claims
- 0990US12077579B2Use of anti-FAM19A5 antibodies for treating fibrosisNEURACLE SCIENCE CO LTD·Filed 2021·Granted Sep 3, 2024·1 cites·12 claims
- 1089US11634484B2Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic painNEURACLE SCIENCE CO LTD·Filed 2019·Granted Apr 25, 2023·9 cites·15 claims
- 1185US12435130B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·15 claims
- 1284US11970532B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Apr 30, 2024·4 cites·15 claims
- 1384US2025236663A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 1483US12492246B2Anti-FAM19A5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2023·Granted Dec 9, 2025·0 cites·9 claims
- 1581US12466880B2Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucomaNEURACLE SCIENCE CO LTD·Filed 2023·Granted Nov 11, 2025·0 cites·18 claims
- 1678US12202889B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·16 claims
- 1778US10385098B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2016·Granted Aug 20, 2019·3 cites·20 claims
- 1878US2025354169A1Adeno-associated virus (aav) delivery of anti-fam19a5 antibodiesNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 1975US2023348584A1Use of anti-fam19a5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 2075US2025263479A1Pharmaceutical use of fam19a5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2173US2025333491A1Anti-fam19a5 antibodies and uses thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2271US12072339B2Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disordersNEURACLE SCIENCE CO LTD·Filed 2018·Granted Aug 27, 2024·1 cites·14 claims
- 2371US11248023B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 2471US2025353902A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2570US2024360209A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 2668US2023357378A1Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of neuropathic painNEURACLE SCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 2766US2025289881A1Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of glaucomaNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 2865US12492244B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Dec 9, 2025·0 cites·18 claims
- 2965US2025289880A1Use of anti-fam19a5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 3065US2022242910A1Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3165US2025067755A1Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment and diagnosis of mood disordersNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 3264US12215338B2Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodiesNEURACLE SCIENCE CO LTD·Filed 2019·Granted Feb 4, 2025·0 cites·20 claims
- 3360US2025368731A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 3458US2024238445A1Inhibitors and uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3556US2025333441A1Polypeptide inhibitors and uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3656US2024175880A1Lrrc4 family mimic molecules and diagnostic uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 3752US12459995B2Use of anti-FAM19A5 antibodiesNEURACLE SCIENCE CO LTD·Filed 2019·Granted Nov 4, 2025·0 cites·17 claims
- 3852US2023104540A1Use of anti-fam19a1 antagonists for treating central nervous system diseasesNEURACLE SCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 3950US12247070B2Use of anti-FAM19A5 antibodies for treating atherosclerosisNEURACLE SCIENCE CO LTD·Filed 2019·Granted Mar 11, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when NEURACLE SCIENCE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →